Clinical usefulness of measuring red blood cell distribution width on admission in patients with acute coronary syndromes

Clinical Chemistry and Laboratory Medicine

Volumn 47, Issue 3, 2009, Pages 353-357

  Lippi, Giuseppe ^a   Filippozzi, Luca ^b   Montagnana, Martina ^a   Salvagno, Gian Luca ^a   Franchini, Massimo ^c   Guidi, Gian Cesare ^a   Targher, Giovanni ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

^c UNIVERSITY OF PARMA   (Italy)

Author keywords

Acute coronary syndrome; Myocardial infarction; Red blood cell distribution width

Indexed keywords

TROPONIN T;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE MARKER; ELECTROCARDIOGRAPHY; ERYTHROCYTE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ACUTE CORONARY SYNDROME; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; ERYTHROCYTE INDICES; FEMALE; HUMANS; MALE; MIDDLE AGED; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 63849158753     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2009.066     Document Type: Article

References (24)

1. Lippi G, Montagnana M, Salvagno GL, Guidi GC. Potential value for new diagnostic markers in the early recognition of acute coronary syndromes. CJEM 2006;8:27-31.
2. Apple FS, Wu AH. Myocardial infarction redefined: role of cardiac troponin testing. Clin Chem 2001;47:377-9.
3. Bayley MD, Schwartz JS, Shofer FS, Weiner M, Sites FD, Traber KB, et al. The financial burden of emergency department congestion and hospital crowding for chest pain patients awaiting admission. Ann Emerg Med 2005; 45:110-7.
4. Tefferi A, Hanson CA, Inwards DJ. How to interpret and pursue an abnormal complete blood cell count in adults. Mayo Clin Proc 2005;80:923-36.
5. Evans TC, Jehle D. The red blood cell distribution width. J Emerg Med 1991;9(Suppl 1):71-4.
6. Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray JJ, Pfeffer MA, et al.; CHARM Investigators, et al.; CHARM Investigators. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol 2007;50: 40-7.
7. Tonelli M, Sacks F, Arnold M, Moye L, Davis B, Pfeffer M; for the Cholesterol and Recurrent Events (CARE) Trial Investigators. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation 2008;117:163-8.
8. Dolci A, Dominici R, Luraschi P, Panteghini M. 10% CV concentration for the fourth generation Roche cardiac troponin T assay derived from internal quality control data. Clin Chem Lab Med 2006;44:1495-6.
9. Wu AH, Jaffe AS. The clinical need for high-sensitivity cardiac troponin assays for acute coronary syndromes and the role for serial testing. Am Heart J 2008;155: 208-14.
10. Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/ WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. J Am Coll Cardiol 2007;50:2173-95.
11. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, et al; American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction); American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons; American Association of Cardiovascular and Pulmonary Rehabilitation; Society for Academic Emergency Medicine. ACC/AHA 2007 guidelines for the management of patients with unstable angina/ non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 2007;116: e148-304.
12. Panteghini M, Pagani F, Bonetti G. The sensitivity of cardiac markers: an evidence-based approach. Clin Chem Lab Med 1999;37:1097-106.
13. Morrow DA, Cannon CP, Jesse RL, Newby LK, Ravkilde J, Storrow AB, et al; National Academy of Clinical Biochemistry. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin Chem 2007;53:552-74.
14. Amodio G, Antonelli G, Varraso L, Ruggieri V, Di Serio F. Clinical impact of the troponin 99th percentile cut-off and clinical utility of myoglobin measurement in the early management of chest pain patients admitted to the Emergency Cardiology Department. Coron Artery Dis 2007;18:181-6.
15. Svensson L, Axelsson C, Nordlander R, Herlitz J. Elevation of biochemical markers for myocardial damage prior to hospital admission in patients with acute chest pain or other symptoms raising suspicion of acute coronary syndrome. J Intern Med 2003;253:311-9.
16. Gust R, Gust A, Bottiger BW, Bohrer H, Martin E. Bedside troponin T testing is not useful for early out-of-hospital diagnosis of myocardial infarction. Acta Anaesthesiol Scand 1998;42:414-7.
17. Newman J, Aulick N, Cheng T, Faynor S, Curtis R, Mercer D, et al. Prehospital identification of acute coronary ischemia using a troponin T rapid assay. Prehosp Emerg Care 1999;3:97-101.
18. Svensson L, Axelsson C, Nordlander R, Herlitz J. Prognostic value of biochemical markers, 12-lead ECG and patient characteristics amongst patients calling for an ambulance due to a suspected acute coronary syndrome.J Intern Med 2004;255:469-77.
19. Schuchert A, Hamm C, Scholz J, Klimmeck S, Goldmann B, Meinertz T. Prehospital testing for troponin T in patients with suspected acute myocardial infarction. Am Heart J 1999;138:45-8.
20. Tanaka K, Seino Y, Ohbayashi K, Takano T. Cardiac emergency triage and therapeutic decisions using whole blood rapid troponin T test for patients with suspicious acute coronary syndrome. Jpn Circ J 2001;65:424-8.
21. Nagurney JT, Brown DF, Chae C, Chang Y, Chung WG, Cranmer H, et al. The sensitivity of cardiac markers stratified by symptom duration. J Emerg Med 2005;29: 409-15.
22. Eggers KM, Oldgren J, Nordenskjö ld A, Lindahl B. Diagnostic value of serial measurement of cardiac markers in patients with chest pain: limited value of adding myoglobin to troponin I for exclusion of myocardial infarction. Am Heart J 2004;148:574-81.
23. Balk EM, Ioannidis JP, Salem D, Chew PW, Lau J. Accuracy of biomarkers to diagnose acute cardiac ischemia in the emergency department: a meta-analysis. Ann Emerg Med 2001;37:478-94.
24. Panteghini M, Apple FS, Christenson RH, Dati F, Mair J, Wu AH; IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage. Use of biochemical markers in acute coronary syndromes. Clin Chem Lab Med 1999;37:687-93.